Analyst firms · Leerink Partners · PLRX
Leerink Partners PLRX price target and rating history
Pliant Therapeutics Inc. (PLRX) · Health Care
Leerink Partners rates Pliant Therapeutics Inc. (PLRX) Market Perform with a $33 price target, as of its latest action on Mar 3, 2025. It has published 3 rating actions on PLRX since July 2022, including 0 upgrades and 1 downgrade.
- Current rating
- Market Perform
- Price target
- $33
- Median target, all firms
- Too few
- Actions on PLRX
- 3
Leerink Partners price target on PLRX
Every Leerink Partners rating on PLRX
- Mar 3, 2025
- Sep 9, 2024
- Jul 20, 2022
Questions about Leerink Partners and PLRX
- What is Leerink Partners's price target for PLRX?
- Leerink Partners's latest stated price target for Pliant Therapeutics Inc. (PLRX) is $33, from its action on Sep 9, 2024.
- What is Leerink Partners's rating on PLRX?
- Leerink Partners rates PLRX Market Perform, a neutral rating, as of Mar 3, 2025.
- When did Leerink Partners last change its view on PLRX?
- On Mar 3, 2025, Leerink Partners downgrades to Market Perform from Outperform.
All Leerink Partners ratingsPLRX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.